CtrlK
BlogDocsLog inGet started
Tessl Logo
SkillPublic

tooluniverse-drug-repurposing

Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies. Combines drug-target-disease network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility. Use for hypothesis-generating repurposing for orphan diseases, finding existing drugs for new indications, and prioritizing candidates by evidence and feasibility.

Quality

83%

Does it follow best practices?

Run evals on this skill

Adds up to 20 points to the overall score

View guide
SecuritybySnyk

Low

Low-risk findings worth noting

SKILL.md
Quality
Evals
Security

Quality

Content

71%Weight 40%Scale 1-5

Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.

The body is an information-dense, highly actionable operations manual with real parameter and API gotchas, a clear phased workflow, and strong decision frameworks. Its main weaknesses are the four dangling references to bundle files that do not exist, inlined detailed sections that belong in those reference files, and a partially pseudocode dose-feasibility example.

Suggestions

Ship the referenced bundle files (PROCEDURES.md, REFERENCE.md, EXAMPLES.md, REPORT_TEMPLATE.md) or remove/repair the pointers — currently every reference in the body and the Reference Files section resolves to nothing in the skill directory.

Move the detailed Patent Landscape Check, Signature-Based Repurposing, and Cross-Knowledge-Graph sections (and possibly the full tool catalog) into the reference files, keeping only a tool table and one-line pointers in SKILL.md to reduce context load.

Replace the `pass # Parse actual values from results` placeholder in the dose-feasibility check with executable IC50/Ki extraction code so the procedure runs as written.

DimensionReasoningScore

Conciseness

The body is dense with genuinely non-obvious information — parameter gotchas ("Param: `query=` (NOT `target_name=`)", "newline-separated string, NOT array"), response-nesting paths, and API-key requirements — and avoids explaining concepts Claude already knows. Minor trimmable instances remain: the patent 403/404 explanation is repeated in the Troubleshooting table, "check clinical trials first" appears in both Best Practices and the interpretation questions, and the "Verified live" narrative paragraphs are wordier than needed. Efficient with minor over-explanation, not the unnecessary-concept explanation of a 3.

4 / 5

Actionability

Mostly executable guidance: a copy-paste-ready Quick Start with parsing paths, exact tool names with required parameter forms, concrete scoring thresholds ("IC50 > 10x original → flag as unlikely feasible"), and worked parameter examples ("identifiers=\"SOD1\\nTARDBP\\nFUS\""). It falls short of 5 because the dose-feasibility code block ends in `pass # Parse actual values from results` (pseudocode) and the patent and LINCS workflows are prose-only without runnable examples — minor but real gaps.

4 / 5

Workflow Clarity

The 5-phase workflow is clearly sequenced, with an explicit strategy-selection gate ("Identify which strategy applies FIRST... Do not run all three strategies blindly"), interpretation questions that act as synthesis checkpoints, and a troubleshooting table for error recovery. It does not reach 5 because the per-phase steps are one-line summaries deferred to PROCEDURES.md, which is not present in the bundle, leaving the detailed sequence underspecified in the file itself.

4 / 5

Progressive Disclosure

The file is well-sectioned and signals its references clearly ("See: PROCEDURES.md", plus a Reference Files list), but the referenced files — PROCEDURES.md, REFERENCE.md, EXAMPLES.md, REPORT_TEMPLATE.md — do not exist anywhere in the bundle (no references/, scripts/, or assets/ directories), so every external pointer is dangling. Additionally, substantial detailed content (full tool catalog, ~20-line patent landscape section, signature-based and Translator sections) is inlined in SKILL.md rather than split out, matching the anchor for structure present but content that should be separate kept inline.

3 / 5

Total

15

/

20

Passed

Description

87%Weight 40%Scale 1-5

Based on the skill's description, can an agent find and select it at the right time? Clear, specific descriptions lead to better discovery.

A strong description: it states concrete capabilities, explicitly couples them to a multi-strategy domain framing, and provides an explicit "Use for..." clause with natural trigger scenarios. The only minor gap is missing common synonyms (e.g., drug repositioning) that would round out trigger coverage.

DimensionReasoningScore

Specificity

The description names the domain and several concrete capabilities: "Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies", "Combines drug-target-disease network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility", and "prioritizing candidates by evidence and feasibility". It does not reach the 5 anchor's comprehensive enumeration of concrete actions because the strategies are named as categories rather than fully unpacked actions, leaving minor coverage gaps.

4 / 5

Completeness

Both questions are explicitly answered: the what ("Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies... Combines... network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility") and an explicit when clause with concrete trigger scenarios ("Use for hypothesis-generating repurposing for orphan diseases, finding existing drugs for new indications, and prioritizing candidates by evidence and feasibility"). This matches the 5 anchor pattern of a clear what followed by explicit use-when trigger phrases.

5 / 5

Trigger Term Quality

Natural phrases a user would actually say are present: "drug repurposing", "repurposing candidates", "orphan diseases", "finding existing drugs for new indications", "prioritizing candidates". Not a 5 because common synonyms and variations such as "drug repositioning" or "off-label use" are missing, so keyword coverage is good but not comprehensive.

4 / 5

Distinctiveness Conflict Risk

The description carves out a clear niche — drug repurposing candidate identification with patent/regulatory feasibility — with trigger terms (repurposing, orphan diseases, new indications) that are unlikely to collide with generic search, document, or data-analysis skills. Minimal conflict risk.

5 / 5

Total

18

/

20

Passed

Validation

100%

Checks the skill against the spec for correct structure and formatting. All validation checks must pass before discovery and implementation can be scored.

Validation — 16 / 16 Passed

Validation for skill structure

No warnings or errors.

Repository

mims-harvard/ToolUniverse

Path

plugin/skills/tooluniverse-drug-repurposing/SKILL.md

Reviewed

Table of Contents

Is this your skill?

If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.